Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Fisher & Paykel Healthcare drives sharemarket up
Markets Market Close

Fisher & Paykel Healthcare drives sharemarket up

The S&P/NZX 50 Index closed up 0.61% or 81.576 points to 13,562.01.

Tom Raynel 26 Nov 2025
Rakon stock-price climbs ahead of result
Markets

Rakon stock-price climbs ahead of result

Rakon shares rose almost 9% on Wednesday but spiked even higher during the day.

Fisher Funds backs Summerset in rejecting covenant waiver claims
Markets

Fisher Funds backs Summerset in rejecting covenant waiver claims

Summerset is compliant with all lending covenants and obligations.

Rebecca Howard 26 Nov 2025
Critical minerals miner plans 2026 NZX listing
Primary Sector

Critical minerals miner plans 2026 NZX listing

The company plans to raise $20m from retail investors in mid-2026.

Pattrick Smellie 26 Nov 2025